Takeshi Ujike

Papers

Total Citations

H-Index

About

Dr. Takeshi Ujike is a leading urologic oncologist whose research focuses on nephron-sparing treatments for renal cell carcinoma (RCC), particularly comparing the efficacy of minimally invasive surgical techniques. His most cited work, a 2021 study on robot-assisted partial nephrectomy (RAPN) versus percutaneous cryoablation (PCA) for T1 RCC, has garnered 19 citations and addresses a critical gap in the literature by directly comparing oncological outcomes and renal function preservation between these two approaches. Through retrospective analysis of 126 patients, Dr. Ujike provides valuable clinical insights that guide treatment decisions for early-stage kidney cancer. His contributions are especially significant for patients seeking to balance cancer control with maximal kidney function retention. By systematically evaluating these nephron-sparing modalities, Dr. Ujike has helped clarify the relative benefits and limitations of robotic surgery versus thermal ablation, influencing urologic practice. His work continues to shape the evidence base for personalized, minimally invasive management of small renal masses, making him a respected voice in the evolving landscape of urologic oncology.